DAIC

DECEMBER 19, 2023

Image courtesy: Peerbridge Health christine.book Tue, 12/19/2023 - 10:22 December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% David's Medical Center.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

CineECG

MAY 22, 2023

HRS 2023 is a wrap! As ECG Excellence we are proud our CineECG technology was part of this innovation festival. Exiting news regarding the use of CineECG in localizing the origin of atrial ectopic activity. Results of two studies, conducted by our research partners, and supported by our Scientific team, were presented.

Technology 52

Technology Atrial Fibrillation Anatomy Innovation 52

DAIC

DECEMBER 26, 2023

milla1cf Tue, 12/26/2023 - 21:19 December 26, 2023 — Pulse Biosciences, Inc. , Patients will continue to be monitored and evaluated over the coming months to assess safety and effectiveness with the primary safety endpoint at 30 days.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

DAIC

MARCH 31, 2025

arrhythmia yield versus 69.1% in daily-symptom patients, demonstrating that greater symptom frequenc y does not necessarily reflect increased arrhythmia burden. arrhythmia yield versus 69.1% in daily-symptom patients, demonstrating that greater symptom frequenc y does not necessarily reflect increased arrhythmia burden.

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. FDA 510(k) clearance and European CE Mark approval for its innovative products. The company has obtained U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

MARCH 28, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. In Europe, the TRUPULSE generator received CE mark in late 2023 and the VARIPULSE Catheter received CE mark in February 2024. In the U.S.,

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

DAIC

FEBRUARY 1, 2024

Elevated levels of two protein biomarkers that indicate heart damage were associated with undetected or symptomless cardiovascular disease in adults with Type 2 diabetes compared to those without Type 2 diabetes, according to new research published May 31, 2023, in the Journal of the American Heart Association, JAHA. In addition, 115.9

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Stroke Strokes 104

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). [ii]

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

DECEMBER 20, 2023

Image courtesy of MMRI milla1cf Wed, 12/20/2023 - 15:57 December 20, 2023 — Jason R. As a result of McCarthy’s findings, there is a potential for his strategy to be used more clinically, to significantly reduce cardiac damage and possibly prevent a second event or an arrhythmia following a heart attack. Jason McCarthy, Ph.D.,

Heart Attack 115

Heart Attack Heart attacks Myocardial Infarction Research 115

DAIC

SEPTEMBER 5, 2024

ICDs are safe and effective for terminating life-threatening ventricular arrhythmias; transvenous leads, which run through the veins and into the heart, can result in complications. Food and Drug Administration approval in 2023, and is now available in 29 countries around the world. 1 Friedman P, et al. N Engl J Med. 2024;35:240-246.

Defibrillator 52

Defibrillator Sudden Cardiac Death Quality of Life Tachycardia 52

Dr. S. Venkatesan MD

FEBRUARY 20, 2024

In myocardial pathology, the genesis and sustainability of ventricular arrhythmia are intricately related to the degree of LV dysfunction of any cause. Still, Mirowski”s electrical kid survived the test of time and evolved with great technological innovations from companies like Medtronic, Guidant, Abbot etc.

Defibrillator 52

Defibrillator Heart Failure Sudden Cardiac Death Cardiomyopathy 52

DAIC

OCTOBER 30, 2024

The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath. "The

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52